These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9353749)

  • 21. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes.
    Sulavik MC; Houseweart C; Cramer C; Jiwani N; Murgolo N; Greene J; DiDomenico B; Shaw KJ; Miller GH; Hare R; Shimer G
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1126-36. PubMed ID: 11257026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli.
    Yang S; Clayton SR; Zechiedrich EL
    J Antimicrob Chemother; 2003 Mar; 51(3):545-56. PubMed ID: 12615854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of NlpE overproduction on multidrug resistance in Escherichia coli.
    Nishino K; Yamasaki S; Hayashi-Nishino M; Yamaguchi A
    Antimicrob Agents Chemother; 2010 May; 54(5):2239-43. PubMed ID: 20211889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of outer membrane in Serratia marcescens intrinsic resistance to antibiotics.
    Sánchez L; Ruiz N; Leranoz S; Viñas M; Puig M
    Microbiologia; 1997 Sep; 13(3):315-20. PubMed ID: 9353750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic resistance and clinical significance of Haemophilus influenzae type f.
    Campos J; Román F; Pérez-Vázquez M; Aracil B; Oteo J; Cercenado E;
    J Antimicrob Chemother; 2003 Dec; 52(6):961-6. PubMed ID: 14613949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prokaryote multidrug efflux proteins of the major facilitator superfamily: amplified expression, purification and characterisation.
    Ward A; Hoyle C; Palmer S; O'Reilly J; Griffith J; Pos M; Morrison S; Poolman B; Gwynne M; Henderson P
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):193-200. PubMed ID: 11321573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three's company: component structures bring a closer view of tripartite drug efflux pumps.
    Eswaran J; Koronakis E; Higgins MK; Hughes C; Koronakis V
    Curr Opin Struct Biol; 2004 Dec; 14(6):741-7. PubMed ID: 15582398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC.
    Li B; Yao Q; Pan XC; Wang N; Zhang R; Li J; Ding G; Liu X; Wu C; Ran D; Zheng J; Zhou H
    J Antimicrob Chemother; 2011 Apr; 66(4):769-77. PubMed ID: 21393180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Problems in studying sensitivity in Haemophilus influenzae].
    Perea EJ
    Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):45-50. PubMed ID: 8461373
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular determinants of AcrB-mediated bacterial efflux implications for drug discovery.
    Manchester JI; Buurman ET; Bisacchi GS; McLaughlin RE
    J Med Chem; 2012 Mar; 55(6):2532-7. PubMed ID: 22224562
    [No Abstract]   [Full Text] [Related]  

  • 32. The channel-tunnel HI1462 of Haemophilus influenzae reveals differences to Escherichia coli TolC.
    Polleichtner G; Andersen C
    Microbiology (Reading); 2006 Jun; 152(Pt 6):1639-1647. PubMed ID: 16735727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A major outer-membrane protein functions as a porin in Haemophilus influenzae.
    Burns JL; Smith AL
    J Gen Microbiol; 1987 May; 133(5):1273-7. PubMed ID: 2443611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli.
    McMurry LM; Oethinger M; Levy SB
    FEMS Microbiol Lett; 1998 Sep; 166(2):305-9. PubMed ID: 9770288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phylogenetic and functional characterisation of the
    Zwama M; Yamaguchi A; Nishino K
    Commun Biol; 2019; 2():340. PubMed ID: 31531401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Active efflux of bile salts by Escherichia coli.
    Thanassi DG; Cheng LW; Nikaido H
    J Bacteriol; 1997 Apr; 179(8):2512-8. PubMed ID: 9098046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug-exporting secondary transporters.
    Murakami S; Yamaguchi A
    Curr Opin Struct Biol; 2003 Aug; 13(4):443-52. PubMed ID: 12948774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overlaps and parallels in the regulation of intrinsic multiple-antibiotic resistance in Escherichia coli.
    Miller PF; Sulavik MC
    Mol Microbiol; 1996 Aug; 21(3):441-8. PubMed ID: 8866468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular analysis of efflux pump-based antibiotic resistance.
    Zgurskaya HI
    Int J Med Microbiol; 2002 Jul; 292(2):95-105. PubMed ID: 12195740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aminoglycoside resistance in Haemophilus influenzae.
    Gomez-Lus R; Vergara Y
    J Chemother; 1995 Apr; 7(2):97-9. PubMed ID: 7666127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.